Results for &quot;&quot;Receptors, Gastrointestinal Hormone&quot;&quot;[mesh_terms]

Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor.

Juliana E Milburn, Kaleeckal G Harikumar, Sarah J Piper, Sweta Raval, Arthur Christopoulos, Denise Wootten, Patrick M Sexton, Laurence J Miller

Molecular pharmacology 2022;101(6):400-407

Glucose-dependent insulinotropic polypeptide as a regulator of beta cell function and fate.

R D Wideman, T J Kieffer

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2005;36(11-12):782-6

Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists.

Gerald Grandl, Brian Finan, Matthias H Tschöp, Richard DiMarchi, Anja Zeigerer, Martin Klingenspor, Kerstin Stemmer, Patrick J Knerr, Maximilian Kleinert, Davide Calebiro, Miriam Bernecker, Shannon L O'Brien, Aaron Novikoff, Timo D Müller

Molecular metabolism 2022;49():101181

TikTok's take on adverse effects for glucagon-like peptide-1 and gastric inhibitory polypeptide receptor agonists.

Jerica Singleton, Gwendolyn A Wantuch

Journal of the American Pharmacists Association : JAPhA 2025;65(4):102384

Insights into the structure of class B GPCRs.

Raymond C Stevens, Fiona H Marshall, Ming-Wei Wang, Andrea Bortolato, Chris de Graaf, Kaspar Hollenstein

Trends in pharmacological sciences 2014;35(1):12-22

Pharmacotherapy for intestinal motor and sensory disorders.

William L Hasler

Gastroenterology clinics of North America 2003;32(2):707-32, viii-ix

Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men.

Mark J Dekker, Terry E Graham, T C Ooi, Lindsay E Robinson

The Journal of nutritional biochemistry 2011;21(10):983-90

Predicting the effects of amino acid replacements in peptide hormones on their binding affinities for class B GPCRs and application to the design of secretin receptor antagonists.

Jerez A Te, Maoqing Dong, Laurence J Miller, Andrew J Bordner

Journal of computer-aided molecular design 2012;26(7):835-45

Review Article: GLP-1 Receptor Agonists and Glucagon/GIP/GLP-1 Receptor Dual or Triple Agonists-Mechanism of Action and Emerging Therapeutic Landscape in MASLD.

Federica Tavaglione, Manuel Romero-Gómez, Rohit Loomba, Maryam Zafer

Alimentary pharmacology & therapeutics 2025;61(12):1872-1888

Treatment of refractory gastroparesis: gastric and jejunal tubes, botox, gastric electrical stimulation, and surgery.

Reza A Hejazi, Richard W McCallum

Gastrointestinal endoscopy clinics of North America 2010;19(1):73-82, vi

A multicenter, randomized, double-blind, placebo-controlled trial of the prokinetic agent erythromycin in the postoperative recovery of infants with gastroschisis.

J I Curry, A D Lander, M D Stringer

Journal of pediatric surgery 2004;39(4):565-9

Cystic fibrosis related diabetes--a new perspective on the optimal management of postprandial glycemia.

M Horowitz, J Martin, J Couper, C K Rayner, S Perano

Journal of diabetes and its complications 2015;28(6):904-11

Treatment of gastroparesis: an update.

Vivek Gumaste, Joel Baum

Digestion 2009;78(4):173-9

Ab initio modelling of the N-terminal domain of the secretin receptors.

Robin E J Munro, Kjell Petersen, Robert P Bywater, William R Taylor

Computational biology and chemistry 2003;27(2):103-14